- WP Carey reported a fourth-quarter revenue of $406.2 million, exceeding the estimate of $400.9 million.
- Adjusted Funds from Operations (AFFO) per share for the fourth quarter was $1.21.
- The company announced a 2025 AFFO guidance range of $4.82 to $4.92 per diluted share.
- For 2025, WP Carey anticipates a total investment volume between $1.0 billion and $1.5 billion.
- The guidance is approached cautiously due to uncertainty in the broader market, including interest rate trends and macroeconomic factors.
- Current analyst recommendations include 2 buys, 9 holds, and 3 sells.
A look at Wp Carey Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
WP Carey Inc. is set to maintain a robust financial position according to the Smart Scores analysis. With a solid Value score of 4, the company is considered to be priced attractively in relation to its fundamentals. Furthermore, its Dividend score of 5 signifies a strong potential for consistent and lucrative dividend payouts to investors, making it an attractive option for those seeking income.
However, the company’s Growth score of 3 indicates moderate future growth prospects, while its Resilience score of 2 suggests a lower ability to withstand economic downturns. Despite this, WP Carey Inc.’s Momentum score of 3 reflects a stable performance trend in the market. Overall, WP Carey Inc. appears to be a promising investment opportunity for those looking for value and income in the long run, despite some limitations in growth and resilience aspects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
